Keywords:
Genital / Reproductive system male, MR, Diagnostic procedure, Neoplasia
Authors:
C. Gianneramo1, L. Panebianco1, A. pace1, A. Izzo2, M. Martino3, F. Formiconi1, R. Manetta1, C. Masciocchi1; 1L'Aquila/IT, 2vallata/IT, 3Rome, ITALY/IT
DOI:
10.26044/ecr2019/C-1133
References
[1] Fouad,
Ahmed,
Kotb Shelley,
Spaner Tra,
Crump Matthew,
and Eric Hyndman.
2018.
“The Role of mpMRI and PSA Density in Patients with an Initial Negative Prostatic Biopsy.” (123456789).
[2] Hansen,
Nienke L.
et al.
2017.
“The in Fl Uence of Prostate-Speci Fi c Antigen Density on Positive and Negative Predictive Values of Multiparametric Magnetic Resonance Imaging to Detect Gleason Score 7 – 10 Prostate Cancer in a Repeat Biopsy Setting.” 724–30.
[3] Armstrong,
Andrew J.
2016.
“Prostate Cancer.”
[4] Sim,
Ki Choon et al.
2017.
“Magnetic Resonance Imaging – Based Prostate-Specific Antigen Density for Prediction of Gleason Score Upgrade in Patients With Low-Risk Prostate Cancer on Initial Biopsy.” 41(5):731–36.
[5] Yanai,
Yoshinori et al.
2018.
“Evaluation of Prostate ‑ Specific Antigen Density in the Diagnosis of Prostate Cancer Combined with Magnetic Resonance Imaging before Biopsy in Men Aged 70 Years and Older with Elevated PSA.” 656–60.
[6] Lee,
Findlay Macaskill Su-min et al.
2017.
“Diagnostic Value of MRI-Based PSA Density in Predicting Transperineal Sector-Guided Prostate Biopsy Outcomes.” International Urology and Nephrology.
[7] Lee,
Sue Ji et al.
2018.
“Combined Analysis of Biparametric.” (September):1–7.
[8] Frcr,
Edward W.Johnston et al.
2017.
“Centre for Medical Imaging CO.”